Earnings Call · Q4 FY2022·2023-02-06

Q4 22EPS -13.89%·Rev n/aQ3 22EPS -3.57%·Rev n/aQ2 22EPS -5.62%·Rev n/aQ1 22EPS -49.15%·Rev n/a⚠ consensus missing

NEUROCRINE BIOSCIENCES INC NBIX

Todd Tushla — Investor Relations or IR Host

Kevin Gorman — Chief Executive Officer

Matt Abernethy — Chief Financial Officer

Eric Benevich — Chief Commercial Officer

Eiry Roberts — Chief Medical Officer

−4.6%1d on move date−3.9% vs SPY3d−5.0%5d−6.2%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NBIX calls or request research access.

More NBIX calls Browse calls Request research access